Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02994628 · ClinicalTrials.gov registry record · NA

Banana Cultivars and Exercise Performance and Recovery

A NA study of Inflammation, sponsored by Appalachian State University.

Completed
Registry status
NA
Development phase
23
Enrollment target
1
Study location

NCT02994628 is a NA study of Inflammation that has completed, run by Appalachian State University. The registered enrollment target is 23 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02994628, a NA study of Inflammation, has completed, sponsored by Appalachian State University.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target
1
Study location

Study Summary

In a previous study at the Appalachian State University (ASU) Human Performance Laboratory at the North Carolina Research Campus (NCRC), investigators showed that cyclists ingesting about one-half of a banana with water every 15 minutes cycled 75-km faster (5%) than with water alone. The polyphenols (i.e., chemicals in plants with health benefits) in the banana improved the capacity to counter oxidative stress, and the sugars lowered post-exercise inflammation. The cyclists reported some gastrointestinal discomfort, however, from the high volume of bananas consumed. Dole Foods, the sponsor of this study, has a banana collection that includes many different varieties, including the Mini banana that has a higher sugar (50%) and phenolic (63%) content than the typical banana (Cavendish) available in stores. Thus athletes should experience similar performance benefits from a smaller volume of Mini compared to Cavendish bananas, and reduced gastrointestinal symptoms. If study results are favorable, Dole Foods may market the Mini banana as the "sport" banana. The purpose of this study is to compare ingestion of Mini and Cavendish bananas with an equicaloric, sugar-only beverage or water on 75-km cycling performance and post-exercise oxidative capacity and stress, inflammation, immune function, muscle damage and soreness, and gastrointestinal symptoms.

Conditions Studied

Interventions

  • OTHER Water
  • OTHER Mini banana
  • OTHER Cavendish banana
  • OTHER 6% sugar beverage

Study Locations (1)

North Carolina

  • Human Performance Lab, North Carolina Research Campus - Kannapolis

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2015-11
Est. Completion 2017-01-25
Phase NA

Sponsor

Appalachian State University

37 total trials

What the Registry Record Tells You About NCT02994628

The ClinicalTrials.gov registry entry for NCT02994628 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (92% lower). The listed sponsor is Appalachian State University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Inflammation appearing as the primary indexed condition, and to 4 interventions - of which Water is the first listed.

NCT02994628 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT02994628 about?

NCT02994628 is a clinical study titled "Banana Cultivars and Exercise Performance and Recovery". In a previous study at the Appalachian State University (ASU) Human Performance Laboratory at the North Carolina Research Campus (NCRC), investigators showed that cyclists ingesting about one-half of a banana with water every 15 minutes cycled 75-km faster (5%) than with water alone. The polyphenols...

What is the current status of trial NCT02994628?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2015-11. Estimated completion is 2017-01-25.

What conditions does trial NCT02994628 study?

This clinical trial studies the following conditions: Inflammation.

What interventions are being tested in trial NCT02994628?

The interventions under investigation include: Water (OTHER), Mini banana (OTHER), Cavendish banana (OTHER), 6% sugar beverage (OTHER).

Who is sponsoring clinical trial NCT02994628?

This trial is sponsored by Appalachian State University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02994628 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.